News & Analysis on Clinical Trial Services & Contract Research And Development
Applied Biosystems have taken out a permanent injunction against Bio-Rad Laboratories and its affiliate, MJ Research. This effectively forbids these companies from making and selling infringing thermal cycler products in the US capable of performing...
French drug delivery company Flamel Technologies suffered another blow yesterday when it was revealed that TAP Pharmaceutical Products has pulled out of deal to develop a formulation of its big-selling gastrointestinal drug lansoprazole based on...
Metrohm has developed a robotic analyser that could improve the safety and reduce the cost of non-aqueous titration experiments.
Regulatory obstacles to the development of the market for biogeneric drugs are falling down, and the first products are set to reach the markets of North America and Europe in 2006-7, according to consulting firm Frost & Sullivan.
US researchers believe they have discovered a new method in designing a better drug to treat cystic fibrosis - a disease that currently has no cure. The scientists eventually hope a drug can be produced that would work efficiently and effectively at...
US biotechnology company Chiron has rejected a takeover offer from Swiss drugmaker Novartis, saying the latter's $40 a share offer does not pass muster.
MonoSolRx is planning to develop controlled drugs such as opioid analgesics in its dissolving films, an emerging dosage format for the oral delivery of drugs and nutritonal products.
A recent survey has revealed that Affymetrix continues to lead the DNA microarray market - expected to reach $937 million (€751 million) by 2010. However, Agilent Technologies and Applied Biosystems are eyeing the top position, particularly in the...